Celtaxsys is a privately-held drug discovery and development company focused on advancing treatments for serious inflammatory diseases. The company is building a sustainable pipeline of first-in-class immuno-modulators, the most advanced of which is CTX-4430.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/08/15 | $45,000,000 | Series D |
Domain Associates Georgia Research Alliance Lumira Capital Masters Capital Management RusnanoMedInvest | undisclosed |
